SEC Form 4 · accession 0000878526-16-000136
NATUS MEDICAL INC · BABY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Doris Engibous
Director
Period of report
Apr 22, 2016
Accepted (ET)
Apr 26, 2016 · 8:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000878526
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per share | Apr 22, 2016 | M | 5,000 | $16.78 | A | 18,250 | D | |
| Common Stock, $0.001 par value per shareF1 | Apr 22, 2016 | S | 5,000 | $32.68 | D | 13,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonqualified Stock Option | $16.78 | Apr 22, 2016 | M | 5,000 | D | Jul 3, 2010 | Jun 3, 2016 | Common Stock | 5,000 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $42.00 to $42.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.